1. Cytokine Autoantibodies Are Associated with Infection Risk and Self-Perceived Health:Results from the Danish Blood Donor Study
- Author
-
von Stemann, Jakob H., Pedersen, Ole B., Hjalgrim, Henrik, Erikstrup, Christian, Ullum, Henrik, Thørner, Lise W., Larsen, Margit A.H., Burgdorf, Kristoffer S., Sørensen, Erik, Hansen, Morten B., Ostrowski, Sisse R., von Stemann, Jakob H., Pedersen, Ole B., Hjalgrim, Henrik, Erikstrup, Christian, Ullum, Henrik, Thørner, Lise W., Larsen, Margit A.H., Burgdorf, Kristoffer S., Sørensen, Erik, Hansen, Morten B., and Ostrowski, Sisse R.
- Abstract
The presence of naturally occurring cytokine-specific autoantibodies (c-aAb) in humans is well established, as well as associations to selected pathologies. However, the overall influence of c-aAb on immunocompetence remains largely unknown. In this paper, we performed a large-scale investigation of c-aAb association with infection risk. A cohort of healthy Danish blood donors was screened for c-aAb against IL-1α, IL-6, IL-10, IFNα, and GM-CSF using a Luminex-based multiplex assay, and results were linked to data from the Danish National Prescription Registry. The filing of an antimicrobial prescription following c-aAb measurement was used as a proxy for impaired immunocompetence. We found that c-aAb against pro-inflammatory cytokines IFNα and GM-CSF tended to associate with increased risk of prescription filings in women, whereas antibodies against anti-inflammatory IL-10 were associated with a lower predicted risk of antimicrobial prescriptions, as well as higher self-perceived health scores. We also observed an association of cumulative c-aAb presence with prescription risk. Our data show that cytokine autoantibodies in healthy individuals associate with various proxies for immunomodulation, with the exact association dependent on the pattern of pro- or anti-inflammatory cytokines targeted. This suggests that c-aAb may express cytokine-modulatory properties in healthy individuals and may be critical to further investigate as biomarkers of immunodeficiency.
- Published
- 2020